PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer

被引：0
|
作者：
Xiangyu Qiu
Zhaoan Yu
Xiaoqing Lu
Xin Jin
Jinrong Zhu
Rongxin Zhang
机构：
[1] GuangdongProvincialKeyLaboratoryofAdvancedDrugDelivery,GuangdongProvincialEngineeringCenterofTopicalPreciseDrugDeliverySystem,SchoolofLifeSciencesandBiopharmaceutics,GuangdongPharmaceuticalUniversity
来源：
Cancer Biology & Medicine | 2024年 / 21卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R730.5 [肿瘤治疗学];
学科分类号：
摘要：
<正>The emergence of tumor immunotherapy represents a pivotal milestone in cancer treatment, heralding new hope for cancer patients globally. Immune checkpoint inhibitors have been instrumental in this advance, playing a crucial role in modulating the immune system response to neoplasms. Specifically, the therapies targeting the programmed death 1/programmed cell death ligand 1（PD-1/PD-L1） immune checkpoint pathways have shown significant efficacy in treating various cancers1.
引用
收藏
页码：970 / 976
页数：7
相关论文
共 50 条
  • [1] PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer
    Qiu, Xiangyu
    Yu, Zhaoan
    Lu, Xiaoqing
    Jin, Xin
    Zhu, Jinrong
    Zhang, Rongxin
    CANCER BIOLOGY & MEDICINE, 2024, 21 (11) : 970 - 976
  • [2] LAG-3 and PD-1 blockade raises the bar for melanoma
    Robert, Caroline
    NATURE CANCER, 2021, 2 (12) : 1251 - 1253
  • [3] LAG-3 and PD-1 blockade raises the bar for melanoma
    Caroline Robert
    Nature Cancer, 2021, 2 : 1251 - 1253
  • [4] Role of PD-1 and LAG-3 in cancer immunotherapy.
    Drake, Charles G.
    CANCER RESEARCH, 2013, 73
  • [5] PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
    Tobin, Joshua W. D.
    Bednarska, Karolina
    Campbell, Ashlea
    Keane, Colm
    CELLS, 2021, 10 (05)
  • [6] PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy
    Zahm, Christopher D.
    Moseman, Jena E.
    Delmastro, Lauren E.
    G. Mcneel, Douglas
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [7] The expression of PD-1 and LAG-3 in periapical lesions
    Wang, Hai-Sheng
    Yang, Fu-Hua
    Li, Yuan
    Pei, Fei
    Kulkarni, Ashok B.
    Chen, Zhi
    Zhang, Lu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2677 - 2684
  • [8] LAG-3 expression in advanced basal cell carcinoma (BCC) and tumor regression following combined PD-1/LAG-3 blockade
    Deutsch, J. S.
    Schenk, K. M.
    Soni, A.
    Lipson, E.
    Taube, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S271 - S271
  • [9] Dual blockade of both LAG-3 and PD-1 produce a restorative immune response in a murine colon adenocarcinoma model
    Yu, X.
    Chen, X.
    Liu, J.
    Pu, Q.
    Zhou, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1760 - 1760
  • [10] Combined Immunotherapy for Melanoma: inhibit PD-1 and LAG-3
    Freyer, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (10) : 446 - 446
12345